LEARNING OBJECTIVES 1. Review the current treatment landscape for MDS and myeloproliferative neoplasms 2. Understand the rationale for novel combination strategies 3. Discuss ongoing investigator-initiated trial and correlative translational studies
Session date:
12/08/2022 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Gregory Roloff, MD